Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Formulation and Evaluation of Telmisartan Fast Dissolving Tablets by Direct Compression Method


Affiliations
1 Himachal Institute of Pharmaceutical Education and Research, Nadaun, Hamirpur, H.P., India
2 Department of Pharmacy, Coimbatore Government Medical College, Coimbatore, India
     

   Subscribe/Renew Journal


Telmisartan is a ACE inhibitor anti-hypertensive drug. Hence, in the present work, Telmisartan fast dissolving tablets will be prepared by using different super disintegrating agents. The amount of drug that is subject to first pass metabolism is reduced as compared to mouth dissolving tablets. Orally disintegration tablets contain wide variety of pharmaceutical active ingredients covering many therapeutic categories. The time for disintegration of orally disintegrating tablets are generally considered less than one minute. Orally disintegrating tablets are characterized by high porosity, low density and low hardness. The blend was examined for the precompressional parameters and post-compression parameters. Drug compatibility with excipients was checked by FTIR studies. The values of pre-compression parameters evaluated were within prescribed limits and indicated good free flowing property. In all the formulations, friability is less than 1%, indicated that tablets had a good mechanical resistance. Drug content was found to be in the range of 98 to 102%, which is within acceptable limits. Hardness of the tablets was found to be in the range of 3-4 Kp. The in vitro dispersion time was found to be in the range of 38-112sec with rapid in vitro dissolution within 3 min. No chemical interaction between drug and excipients was confirmed by FTIR studies. The drug release from tablets of Telmisartan prepared by direct compression showed that 98.20% drug release within 15 minutes.

Keywords

Telmisartan, Fast Dissolving Tablets, Super Disintegrants.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Aulton M, Pharmaceutics, The Science Of Dosage Form Design, International student edition, published by Churchill Livingstone, 2002, 304-321.
  • Ansel H, Allen L and Jr. Popovich N, Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems, 8th edition, published by Lippincott Williams and Wilkins, 2004, 227-259.
  • Banker GS, Modern pharmaceutics, 3rd edition, Marcel Dekker Inc, New york, 2002, 576 – 820.
  • Bi YX., Sunada, H., 25th edition, “Evaluation of rapidly disintegrating tablets prepared by Direct compression method”, Drug DevInd Pharm, 1999, 571-581.
  • Chen, GL., Kuo MK., 52nd edition, “Formulation Design for Pioglitazone Rapid Release Tablet”, Chinese pharmaceutical Journal, 2000, 295-300.
  • Chaudhari, PD., 42nd edition, “Formulation and evaluation of fast dissolving tablets of Famotidine”, Indian Drugs, 2005, 641649.
  • Herbert A, Lieberman, Leon Lachman and Joseph B. Schwartz, Pharmaceutical Dosage Forms Tablets, 2003, 3rd edition, , 201238.
  • Herbert A, Lieberman, Leon Lachman and Joseph B. Schwartz, Pharmaceutical Dosage Forms Tablets, 2003, 3rd edition, , 1-11.
  • Hinz, B., Hug, AM., “Bioequivalence study of low-dose diclofenac potassium tablet formulations”, Int J Clin Phamacol Ther., 2009, 47th edition, 643-648.
  • Jantratid E., “Reported the bio wavier Monographs for immediately release solid dosage forms cimetidine”, Journal of pharmaceutical Research, 2006, vol: 17, P: 381.
  • Jacob Christensen and Vibeke Wallert Hamsen, Wet granulation in rotary processer and fluid bed: Comparison of granule and tablet properties, AAPS Pharma Sci Tech., Article22, 2006, 7th edition.
  • Kuchekar B.S., Bhises S.B., Arumugam V. Indian J. Pharm. Educ. 2001, 150-152.
  • Lachman L, Lieberman H and Kanig J, The Theory of practice of Industrial pharmacy, 3rdpublished by Lea and Febiger 1986, 346373.
  • Larry Augsburger, L., Huijeoing Hahm, A., Albert Brezeczko, W., Umang shah Super disintegrants: Characterization and function, 2002, 2nd edition, 2623-2638.
  • Mahajan, HS., Rapidly disintegrating tablets for elderly patients. The pharma Review, 8th edition, 2005, 49-52.

Abstract Views: 228

PDF Views: 0




  • Formulation and Evaluation of Telmisartan Fast Dissolving Tablets by Direct Compression Method

Abstract Views: 228  |  PDF Views: 0

Authors

Debjit Bhowmik
Himachal Institute of Pharmaceutical Education and Research, Nadaun, Hamirpur, H.P., India
Rishab Bhanot
Himachal Institute of Pharmaceutical Education and Research, Nadaun, Hamirpur, H.P., India
Darsh Gautam
Himachal Institute of Pharmaceutical Education and Research, Nadaun, Hamirpur, H.P., India
Parshuram Rai
Himachal Institute of Pharmaceutical Education and Research, Nadaun, Hamirpur, H.P., India
K. P. Sampath Kumar
Department of Pharmacy, Coimbatore Government Medical College, Coimbatore, India

Abstract


Telmisartan is a ACE inhibitor anti-hypertensive drug. Hence, in the present work, Telmisartan fast dissolving tablets will be prepared by using different super disintegrating agents. The amount of drug that is subject to first pass metabolism is reduced as compared to mouth dissolving tablets. Orally disintegration tablets contain wide variety of pharmaceutical active ingredients covering many therapeutic categories. The time for disintegration of orally disintegrating tablets are generally considered less than one minute. Orally disintegrating tablets are characterized by high porosity, low density and low hardness. The blend was examined for the precompressional parameters and post-compression parameters. Drug compatibility with excipients was checked by FTIR studies. The values of pre-compression parameters evaluated were within prescribed limits and indicated good free flowing property. In all the formulations, friability is less than 1%, indicated that tablets had a good mechanical resistance. Drug content was found to be in the range of 98 to 102%, which is within acceptable limits. Hardness of the tablets was found to be in the range of 3-4 Kp. The in vitro dispersion time was found to be in the range of 38-112sec with rapid in vitro dissolution within 3 min. No chemical interaction between drug and excipients was confirmed by FTIR studies. The drug release from tablets of Telmisartan prepared by direct compression showed that 98.20% drug release within 15 minutes.

Keywords


Telmisartan, Fast Dissolving Tablets, Super Disintegrants.

References